Restart Life Sciences Corp.
NMLSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $2 | -$0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$1 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$1 | $0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.01 | -0.01 | -30.63 | -0.001 |
| % Growth | 0% | 100% | -4,375,614.3% | – |
| Operating Cash Flow | – | -$0 | -$0 | -$0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | -$0 | -$0 |